Autres langues Standard BioTools Inc.

Actions

LAB

US34385P1084

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
2,44 ^USD	+3,39 %		-3,17 %	+10,41 %

25/04	Mise à jour sectorielle : Les actions du secteur de la santé reculent en fin d'après-midi	MT
25/04	Mise à jour sectorielle : Soins de santé	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sector Update: Health Care Stocks Decline Late Afternoon	25/04
Sector Update: Health Care	25/04
Standard BioTools Initiates Restructuring Plan With 10% Workforce Reduction	25/04
Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024	25/04
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth	25/04
Standard BioTools Inc. Announces Operational Restructuring Plan	25/04
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging	08/04
Standard BioTools Inc. Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the Boundaries of Tissue Imaging	08/04
Sector Update: Health Care Stocks Lean Higher Pre-Bell Thursday	04/04
Standard BioTools Enters Into Multi-Year Medicine Research Engagement With Bristol-Myers Squibb	04/04
Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research	03/04
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock	18/03
Standard BioTools: Q4 Earnings Snapshot	28/02
Standard BioTools Inc. Provides Revenue Guidance for the Full Year 2024	28/02
Standard BioTools Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02
Standard BioTools Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q4 Revenue $28.2M, vs. Street Est of $24.9M	28/02
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results	28/02
Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing	26/02
Standard BioTools Inc. and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing	26/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Standard BioTools Inc.

Actions

LAB

US34385P1084

Autres langues

Filtres